Trading Pte. Ltd. (“Cargill”)) and acquired the aforesaid debts in the amount totaling to USD 226,331,648 or equivalent to THB 7,810,529,136.75 (consisting of principal of USD 127,885,456 or equivalent to
Wattanapat Samui Hospital is approximately 425 million Baht which is composed of the land cost including fee from transferring ownership for 218 Million Baht( the ownership transfer cost 3 Million Baht
45.4% from 39.9% in previous year. Selling and administration expense. Selling and administration expense (“SG&A”) closed at 97.39 mb (2017: 82.75 mb), an increase of 14.64 mb or 17.7 %. SG&A is composed
in 2019, but dropped when compared with total revenues by 3 .5 % year-on-year. Selling expenses mainly varied in accordance with total sales, composed principally of salary, bonus and commission fee
total revenues by 3 .5 % year-on-year. Selling expenses mainly varied in accordance with total sales, composed principally of salary, bonus and commission fee for sales staff, traveling and vehicle
Wattanapat Samui Hospital is approximately 425 Baht which is composed of the land expense for 223 Million Baht, construction expense is 165.35 Million Baht and the medical instruments is 36.65 Million Baht
Wattanapat Samui Hospital is approximately 425 Baht which is composed of the land cost including fee from transferring ownership for 223 Million Baht, construction expense is 165.35 Million Baht and the
recoverable amount is lower than the carrying amount. In 2018, the consolidated financial statements has recorded loss from impairment of THB 505 million consisting of impairment goodwill (THB 86 million
12.4 percent, consisting of sales and service income at Baht 417.7 million and other income at Baht 2.5 million. The increase of sales and service revenue was at Baht 45.4 million when comparing with the